Although substantial progress has been made in defining the increased expression of HMOX1 and FADD in PD patients, the possible underlying mechanisms of their expression alterations during PD pathogenesis remain largely unknown and warrant further investigation. This evidence concerns the gene HMOX1 and Parkinson disease.